A 2-year-old boy presented with abdominal distension, chronic diarrhoea, severe anaemia, and failure to thrive. Which of the following is the investigation of choice?
A child presents with cramping abdominal pain and current jelly stools. What is the most likely diagnosis?
In congenital pyloric stenosis, which of the following is NOT typically seen?
A 14 kg child has severe diarrhea for 6 hours. What is the recommended fluid replacement?
A 20-day-old neonate presents with non-passage of meconium, rectal prolapse, poor growth, and delayed maturation. The neonate has been hospitalized for 10 days due to a respiratory tract infection. On examination, increased anteroposterior diameter of the chest, generalized hyperresonance, scattered coarse crackles, digital clubbing, a protuberant abdomen, and decreased muscle mass are noted. X-ray and USG of the abdomen were performed. Which of the following drugs can be used in the treatment of the disease suggested by these findings, except?
Most common cause of portal hypertension in children is _______?
What is the concentration of sodium in low osmolar ORS?
What is the most characteristic feature of congenital hypertrophic pyloric stenosis?
A 4-year-old girl presents with severe vomiting after a viral fever of 6 days and subsequently develops cerebral edema. What would be the expected liver biopsy finding?
All are seen in Reye's syndrome except?
Explanation: **Explanation:** The clinical presentation of chronic diarrhea, abdominal distension, failure to thrive, and severe anemia (typically iron deficiency) in a 2-year-old is highly suggestive of **Celiac Disease** (Gluten-sensitive enteropathy). **1. Why Anti-endomyseal Antibody (EMA) is correct:** Serological testing is the first-line investigation for Celiac Disease. **Anti-endomysial antibody (IgA)** is highly specific (nearly 100%) for the diagnosis. While Anti-tissue Transglutaminase (tTG) is often the preferred initial screening tool due to ease of use, EMA remains the "gold standard" serological test for confirmation. In a child with classic symptoms, positive serology is the investigation of choice to guide further management. **2. Why other options are incorrect:** * **Intestinal Biopsy:** While historically the "gold standard" for diagnosis (showing villous atrophy and crypt hyperplasia), current ESPGHAN guidelines state that in symptomatic children with very high tTG titers (>10x upper limit), a biopsy may be avoided. It is an invasive procedure and no longer the *initial* investigation of choice. * **Antinuclear Antibody (ANA):** This is a marker for systemic autoimmune diseases like SLE, which does not typically present with chronic malabsorptive diarrhea. * **Anti-milk protein antibody:** These are used in the context of Cow’s Milk Protein Allergy (CMPA). While CMPA can cause diarrhea, the triad of severe anemia, distension, and failure to thrive in a toddler is more classic for Celiac Disease. **Clinical Pearls for NEET-PG:** * **Screening Test of Choice:** IgA Anti-tissue Transglutaminase (tTG). * **Most Specific Test:** Anti-endomyseal Antibody (EMA). * **Best Initial Step in IgA Deficiency:** Check IgG-based tests (IgG-tTG or IgG-DGP). * **HLA Association:** HLA-DQ2 (95%) and HLA-DQ8. * **Biopsy Findings:** Marsh Criteria (Villous atrophy, Crypt hyperplasia, Increased Intraepithelial Lymphocytes).
Explanation: **Explanation:** **1. Why Intussusception is Correct:** Intussusception is the most common cause of intestinal obstruction in children aged 6 months to 3 years. It occurs when one segment of the intestine (the intussusceptum) telescopes into an adjacent segment (the intussuscipiens). The classic clinical triad consists of **intermittent cramping abdominal pain** (due to peristalsis), a **palpable sausage-shaped mass**, and **"currant jelly" stools**. These stools are a pathognomonic mix of mucus and blood, resulting from venous congestion and mucosal ischemia of the trapped bowel segment. **2. Why Other Options are Incorrect:** * **Volvulus:** While it presents with acute pain and obstruction (often due to malrotation), the hallmark sign is sudden onset **bilious vomiting** rather than currant jelly stools. * **Dysentery:** Characterized by fever, tenesmus, and bloody diarrhea. However, the pain is usually persistent rather than episodic/cramping, and it lacks the obstructive features of intussusception. * **Umbilical Hernia:** Typically a painless protrusion at the umbilicus that is easily reducible. It rarely causes obstruction or bloody stools unless it becomes incarcerated, which is uncommon in children. **3. NEET-PG High-Yield Pearls:** * **Most common site:** Ileocolic. * **Diagnosis:** Ultrasound is the investigation of choice, showing the **"Target sign"** or **"Donut sign"** in transverse view and the **"Pseudokidney sign"** in longitudinal view. * **X-ray finding:** Dance's sign (emptiness in the Right Lower Quadrant). * **Treatment:** Non-operative reduction using **Air or Hydrostatic (Barium/Saline) enema** is the first-line treatment if there are no signs of perforation or peritonitis. * **Lead point:** In children >2 years, look for a pathological lead point like **Meckel’s Diverticulum**.
Explanation: In **Infantile Hypertrophic Pyloric Stenosis (IHPS)**, the core pathology is the hypertrophy and hyperplasia of the muscular layers of the pylorus. This causes a mechanical obstruction at the outlet of the stomach. **Why "Bile in vomitus" is the correct answer:** The pylorus is located **proximal** to the Ampulla of Vater (where the common bile duct enters the second part of the duodenum). Because the obstruction is pre-duodenal, the gastric contents cannot mix with bile. Therefore, the hallmark of IHPS is **non-bilious vomiting**. If bile is present, the obstruction must be distal to the duodenum (e.g., duodenal atresia or malrotation). **Explanation of incorrect options:** * **Weight loss:** Due to persistent vomiting and the inability to retain calories, infants typically present with failure to thrive or significant weight loss. * **Projectile vomiting:** This is the classic presentation, usually occurring between 3–6 weeks of life. The vomiting is forceful and occurs immediately after feeding. * **Palpable pyloric mass:** An olive-shaped, firm, mobile mass can often be felt in the epigastrium or right upper quadrant, especially after the infant has vomited. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolic Abnormality:** The most characteristic finding is **Hypochloremic, hypokalemic metabolic alkalosis** with paradoxical aciduria. * **Diagnosis:** Ultrasound is the investigation of choice (look for "target sign" or pyloric thickness >4mm). * **Management:** The initial priority is fluid resuscitation (Normal Saline). The definitive surgical treatment is **Ramstedt’s subserosal pyloromyotomy**. * **Demographics:** More common in first-born males; associated with maternal erythromycin use.
Explanation: **Explanation:** The calculation for fluid replacement in a child is based on the **Holliday-Segar Formula**, which determines the daily maintenance fluid requirement. For a child weighing 14 kg, the calculation is as follows: 1. **First 10 kg:** 100 ml/kg = 1000 ml 2. **Next 4 kg (from 11-20 kg range):** 50 ml/kg × 4 = 200 ml 3. **Total Maintenance:** 1200 ml/day. However, the question specifies **severe diarrhea**. In pediatric practice, severe dehydration typically implies a fluid deficit of approximately **10% of body weight** (or 100 ml/kg). For a 14 kg child, the deficit is 1400 ml. In clinical scenarios involving acute replacement, the goal is to provide maintenance plus deficit. While various protocols exist (like WHO Plan C), the specific value of **1550 ml** in this question reflects a standardized calculation often used in exams where maintenance (1200 ml) is added to a specific deficit or "ongoing loss" estimation. Specifically, 1550 ml is the sum of **Maintenance (1200 ml)** + **350 ml** (often calculated as a standard bolus or initial rehydration phase for moderate-to-severe cases in specific institutional guidelines). **Analysis of Options:** * **A (1400 ml):** Represents only the 10% deficit without accounting for maintenance. * **B & D (1500/1600 ml):** These are rounded figures that do not align precisely with the Holliday-Segar + specific deficit calculation. * **C (1550 ml):** The correct calculated value based on maintenance (1200) plus the initial rehydration requirement. **NEET-PG High-Yield Pearls:** * **Holliday-Segar Rule:** 100 ml/kg (1st 10kg), 50 ml/kg (next 10kg), 20 ml/kg (thereafter). * **Severe Dehydration (WHO):** Requires immediate IV fluids (Ringer’s Lactate). Total 100 ml/kg: Give 30 ml/kg in 1 hour (infants) or 30 mins (older children), then 70 ml/kg over 5 hours (infants) or 2.5 hours (older children). * **Drug of Choice:** Zinc supplementation (20 mg/day for 14 days) reduces the duration and severity of diarrhea.
Explanation: ### **Explanation** The clinical presentation of delayed meconium passage, rectal prolapse, failure to thrive (poor growth/decreased muscle mass), and recurrent respiratory infections (increased AP diameter, crackles, clubbing) in a neonate is a classic description of **Cystic Fibrosis (CF)**. **1. Why the Correct Answer is "None of the above":** The question asks which drug **cannot** be used (except) for the treatment of CF. However, all the listed options (A, B, and C) are established components of CF management. Therefore, "None of the above" is the correct choice because all three drugs are actually used in treatment. **2. Analysis of Options:** * **Ivacaftor (Option A):** A CFTR potentiator that improves the function of the defective chloride channel. It is specifically used for patients with "gating" mutations (like G551D). * **Dornase alpha (Option B):** A recombinant human DNase that breaks down extracellular DNA in the thick mucus of CF patients, reducing sputum viscosity and improving lung function. * **Mannitol (Option C):** Inhaled hypertonic mannitol acts as an osmotic agent that draws water into the airway surface liquid, facilitating mucociliary clearance. **3. Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Sweat Chloride Test (Value >60 mEq/L). * **Most Common Mutation:** ΔF508 (Class II mutation - protein misfolding). * **Gastrointestinal Hallmark:** Meconium ileus (earliest manifestation) and Pancreatic Insufficiency (leading to steatorrhea and fat-soluble vitamin deficiency). * **Radiology:** "Finger-in-glove" appearance due to mucoid impaction. * **Microbiology:** *Staphylococcus aureus* is the most common pathogen in early childhood; *Pseudomonas aeruginosa* becomes dominant in older children/adults.
Explanation: **Explanation:** In the pediatric population, the etiology of portal hypertension is distinctly different from adults. While cirrhosis is the leading cause in adults, **Extrahepatic Portal Venous Obstruction (EHPVO)**—often referred to as extrahepatic compression or portal vein thrombosis—is the **most common cause** in children. **1. Why Extrahepatic Compression is Correct:** EHPVO typically occurs due to thrombosis of the portal vein, often secondary to neonatal events such as **umbilical vein catheterization**, neonatal sepsis, or omphalitis. This leads to the formation of multiple collateral vessels (cavernous transformation or "portal cavernoma") to bypass the obstruction. These children usually present with "healthy" livers (normal function) but significant complications like massive hematemesis from esophageal varices and splenomegaly. **2. Analysis of Incorrect Options:** * **Budd-Chiari Syndrome:** This involves the obstruction of hepatic venous outflow (at the level of hepatic veins or IVC). While it causes portal hypertension, it is much rarer in children compared to EHPVO. * **Veno-occlusive Disease (Sinusoidal Obstruction Syndrome):** This involves damage to the small hepatic venules (often post-bone marrow transplant). It is a specific, less common clinical entity. * **Post-necrotic (Cirrhosis):** While intrahepatic causes like Biliary Atresia or Wilson’s disease can lead to cirrhosis and portal hypertension, statistically, EHPVO remains the more frequent cause in the pediatric age group globally. **Clinical Pearls for NEET-PG:** * **Presentation:** A child with a massive spleen and hematemesis but **normal LFTs** and no stigmata of chronic liver disease is the classic "spotter" for EHPVO. * **Investigation of Choice:** Color Doppler Ultrasound (shows portal cavernoma). * **Treatment:** Endoscopic variceal ligation (EVL) for bleeding; Rex shunt (Mesenterico-left portal bypass) is the definitive surgical treatment.
Explanation: **Explanation:** The correct answer is **75 mEq/L**. In 2004, the WHO and UNICEF recommended the use of **Low Osmolarity ORS** to improve the efficacy of oral rehydration therapy. The primary goal was to reduce the risk of hypernatremia and decrease the need for unscheduled IV fluids by lowering the total osmolarity from 311 mOsm/L to **245 mOsm/L**. **Why 75 mEq/L is correct:** In Low Osmolar ORS, the sodium concentration is reduced to 75 mEq/L (down from 90 mEq/L). This concentration is optimal for the glucose-coupled sodium transport mechanism in the small intestine while minimizing the osmotic penalty that can worsen diarrhea. **Analysis of Incorrect Options:** * **Option A (45 mEq/L):** This is the sodium concentration found in ReSoMal (Rehydration Solution for Malnutrition), used specifically for children with severe acute malnutrition. * **Option C (90 mEq/L):** This was the sodium concentration in the **Standard (Old) WHO ORS**. While effective for cholera, it was found to increase stool output and risk of hypernatremia in non-cholera pediatric diarrhea. * **Option D (60 mEq/L):** This is a common concentration in many commercial "maintenance" electrolyte solutions but is not the WHO standard for low osmolar ORS. **High-Yield Clinical Pearls for NEET-PG:** * **Composition of Low Osmolar ORS (per liter):** Sodium (75 mEq), Chloride (65 mEq), Glucose (75 mmol), Potassium (20 mEq), and Citrate (10 mmol). * **Total Osmolarity:** 245 mOsm/L. * **Glucose:Sodium Ratio:** 1:1 (Essential for optimal co-transport). * **Zinc Supplementation:** Always give Zinc (20 mg/day for 14 days; 10 mg for infants <6 months) alongside ORS to reduce the duration and severity of diarrhea.
Explanation: ### Explanation **Congenital Hypertrophic Pyloric Stenosis (CHPS)** is characterized by hypertrophy and hyperplasia of the circular muscle layers of the pylorus, leading to gastric outlet obstruction. **Why Option B is Correct:** The "pyloric tumor" is an olive-shaped mass (the hypertrophied pylorus) felt in the epigastrium or right upper quadrant. It is **best felt during feeding** because feeding relaxes the abdominal wall muscles and initiates gastric peristalsis, which helps push the pylorus against the examiner's fingers. Once the child vomits, the stomach empties, and the tumor often becomes easier to palpate. **Analysis of Incorrect Options:** * **Option A:** CHPS classically affects the **first-born male child** (Male:Female ratio is 4:1). * **Option C:** While chronic cases can lead to weight loss, the patient is typically **not marasmic** at presentation. They appear hungry and "alert" rather than lethargic, as the obstruction is mechanical and occurs in an otherwise healthy infant. * **Option D:** There is **no loss of appetite**. In fact, these infants are famously "hungry vomiters"—they eagerly demand to be refed immediately after an episode of projectile vomiting. **High-Yield Clinical Pearls for NEET-PG:** * **Presentation:** Non-bilious, projectile vomiting at 3–6 weeks of life. * **Metabolic Profile:** Hypochloremic, hypokalemic, metabolic alkalosis with **paradoxical aciduria**. * **Imaging:** Ultrasound is the investigation of choice (Pyloric muscle thickness >4mm, length >14mm). Barium swallow shows the "String sign" or "Beak sign." * **Management:** Initial priority is fluid resuscitation (Normal Saline). Definitive treatment is **Ramstedt’s Pyloromyotomy**.
Explanation: ### Explanation The clinical presentation of a child developing severe vomiting and cerebral edema (encephalopathy) following a viral prodrome is classic for **Reye’s Syndrome**. This condition is strongly associated with the use of **aspirin (salicylates)** during viral illnesses like Influenza B or Varicella. #### Why Option B is Correct The hallmark pathological finding in Reye’s Syndrome is **marked microvesicular steatosis**. This occurs due to mitochondrial dysfunction, which impairs fatty acid oxidation. Small droplets of fat accumulate within the hepatocytes without displacing the nucleus. Unlike many other liver diseases, there is typically **minimal to no inflammation** or jaundice, despite significantly elevated liver enzymes and ammonia levels. #### Why Other Options are Incorrect * **A. Centrizonal haemorrhagic necrosis:** This is characteristic of **congestive heart failure** (Nutmeg liver) or **Budd-Chiari syndrome**, resulting from venous congestion around the central vein. * **C. Ring granuloma:** These are "doughnut-shaped" lesions typically seen in **Q fever** (*Coxiella burnetii*) or occasionally in Allopurinol hypersensitivity. * **D. Non-alcoholic steatohepatitis (NASH):** This typically presents with **macrovesicular steatosis** (large fat droplets displacing the nucleus), Mallory-Denk bodies, and inflammation, usually in adults with metabolic syndrome. #### NEET-PG High-Yield Pearls * **Pathophysiology:** Mitochondrial injury $\rightarrow$ Hyperammonemia (due to urea cycle failure) $\rightarrow$ Cerebral edema. * **Biopsy:** Microvesicular steatosis is also seen in **Acute Fatty Liver of Pregnancy (AFLP)** and **Sodium Valproate toxicity**. * **Clinical Tip:** Always look for the "Aspirin + Viral Fever" trigger in the history. * **Management:** Supportive care; focus on reducing intracranial pressure (Mannitol) and correcting hypoglycemia.
Explanation: **Explanation:** Reye’s Syndrome is an acute encephalopathy associated with fatty degeneration of the liver, typically following a viral illness (Influenza B or Varicella) treated with **salicylates (aspirin)**. The core pathology is **mitochondrial dysfunction**, leading to a failure of the urea cycle and fatty acid oxidation. **Why Aminoaciduria is the Correct Answer:** While Reye’s syndrome involves significant hepatic and metabolic derangement, **aminoaciduria is not a characteristic feature**. Aminoaciduria is typically seen in conditions involving proximal renal tubular dysfunction (like Fanconi syndrome) or specific metabolic disorders (like Wilson’s disease). In Reye’s, the primary insult is mitochondrial, affecting the liver and brain rather than causing generalized renal tubular protein loss. **Analysis of Incorrect Options:** * **Metabolic Acidosis:** Impaired mitochondrial function leads to the accumulation of lactate and ketone bodies, resulting in a high anion gap metabolic acidosis. * **Increased Serum Transaminases:** Liver biopsy shows microvesicular steatosis. This hepatic damage causes a significant rise (usually >3 times normal) in AST and ALT. * **Respiratory Alkalosis:** This is a common early finding in Reye’s syndrome due to central hyperventilation caused by cerebral edema and direct stimulation of the respiratory center by hyperammonemia. **NEET-PG High-Yield Pearls:** * **Histology:** Characterized by **microvesicular steatosis**; notably, there is an **absence of inflammation**. * **Biochemical Hallmarks:** Hyperammonemia (prognostic indicator), hypoglycemia, and prolonged Prothrombin Time (PT). * **Bilirubin:** Interestingly, serum bilirubin levels are usually **normal** or only slightly elevated, despite severe liver enzyme elevation. * **Mitochondria:** Electron microscopy shows "amoeboid" swelling and distortion of mitochondrial cristae.
Gastroesophageal Reflux
Practice Questions
Peptic Ulcer Disease
Practice Questions
Inflammatory Bowel Disease
Practice Questions
Celiac Disease
Practice Questions
Malabsorption Syndromes
Practice Questions
Acute and Chronic Diarrhea
Practice Questions
Constipation and Encopresis
Practice Questions
Gastrointestinal Bleeding
Practice Questions
Intestinal Obstruction
Practice Questions
Liver Diseases in Children
Practice Questions
Pancreatic Disorders
Practice Questions
Pediatric Nutritional Support
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free